Search research articles
Contact Us
Filters
Showing results (1-10 of 151) with videos related to
Page
of 16
Sort By:
Drugs
|
November 24, 2007
Defining the role of insulin detemir in Basal insulin therapy
Javier Morales
Postgraduate Medicine
|
November 23, 2011
The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors
Javier Morales
Current Pharmaceutical Design
|
April 6, 2019
Limitations and Opportunities in Topical Drug Delivery: Interaction Between Silica Nanoparticles and Skin Barrier
Francisco Arriagada, Javier Morales
Advances in Therapy
|
May 13, 2015
Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira)
Javier Morales, Ludwig Merker
The American Journal of Medicine
|
October 6, 2014
Hypoglycemia
Javier Morales, Doron Schneider
Journal of the American College of Cardiology
|
July 5, 2023
Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week
Javier Morales, Yehuda Handelsman
Postgraduate Medicine
|
February 12, 2024
Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative review
Javier Morales, Biff F Palmer
Diabetes, Obesity & Metabolism
|
April 17, 2018
The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?
Javier Morales, Merces Assumpcao-Morales
Pharmaceutics
|
April 1, 2020
Nanoantioxidant-Based Silica Particles as Flavonoid Carrier for Drug Delivery Applications
Francisco Arriagada, Germán Günther, Javier Morales
Journal of Environmental Management
|
May 11, 2019
Analyzing the social impacts of scooters with geo-spatial methods
Alexey Voinov, Javier Morales, Hanneke Hogenkamp
Page
of 16
Search research articles
Search
Showing results (1-10 of 151) with videos related to
Sort By:
Page
of 16
Drugs
|
November 24, 2007
Defining the role of insulin detemir in Basal insulin therapy
Javier Morales
Postgraduate Medicine
|
November 23, 2011
The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors
Javier Morales
Current Pharmaceutical Design
|
April 6, 2019
Limitations and Opportunities in Topical Drug Delivery: Interaction Between Silica Nanoparticles and Skin Barrier
Francisco Arriagada, Javier Morales
Advances in Therapy
|
May 13, 2015
Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira)
Javier Morales, Ludwig Merker
The American Journal of Medicine
|
October 6, 2014
Hypoglycemia
Javier Morales, Doron Schneider
Journal of the American College of Cardiology
|
July 5, 2023
Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week
Javier Morales, Yehuda Handelsman
Postgraduate Medicine
|
February 12, 2024
Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative review
Javier Morales, Biff F Palmer
Diabetes, Obesity & Metabolism
|
April 17, 2018
The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?
Javier Morales, Merces Assumpcao-Morales
Pharmaceutics
|
April 1, 2020
Nanoantioxidant-Based Silica Particles as Flavonoid Carrier for Drug Delivery Applications
Francisco Arriagada, Germán Günther, Javier Morales
Journal of Environmental Management
|
May 11, 2019
Analyzing the social impacts of scooters with geo-spatial methods
Alexey Voinov, Javier Morales, Hanneke Hogenkamp
Page
of 16